Fundz

ABVC BioPharma reported raising $3.39 Million in an initial SEC Form D filing, from an offering of $3.39 Million

PUBLIC · ABVCNov 02, 2026

Amount Raised

$3.39 Million

$3.39 Million sold, per SEC Form D (first sale Oct 30, 2026)
$3.39 Million per company press release (Nov 2, 2026)

Round Type

Convertible Note

FremontBiotechnologyPharmaceuticalBiopharma

Description

ABVC BioPharma has successfully closed a private placement of original issue discount senior convertible promissory notes, raising approximately $3.39 million. The proceeds will be utilized for general working capital and support subsidiary funding. Additionally, part of the funds will be allocated towards a settlement payment to Lind Global Fund II LP. The offering aligns with ABVC's strategy to enhance its pharmaceutical and medical-device portfolio.

Quick answer

ABVC BioPharma raised $3.39 Million in a Convertible Note round, dated November 2, 2026. ABVC BioPharma is based in Fremont, California, United States.

How much did ABVC BioPharma raise?
ABVC BioPharma raised $3.39 Million in a Convertible Note round on November 2, 2026.
What does ABVC BioPharma do?
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology.
Where is ABVC BioPharma based and how big is it?
ABVC BioPharma is based in Fremont, California, United States. Fundz records about 51 employees.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Biopharma around the same time

Companies in the same sectors as ABVC BioPharma that raised within 45 days of this round, from Fundz verified event records.

  • Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
  • Disc raised $422M (Post-IPO Equity) on October 20, 2026.
  • Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
  • Os Therapies raised $7.2M on October 15, 2026.
  • Scinai Immunotherapeutics Ltd raised $4M (Post-IPO Equity) on October 14, 2026.
  • Telomir Pharmaceuticals raised $5.6M (Post-IPO Equity) on October 6, 2026.

Who to call at ABVC BioPharma, and when

A new round usually means ABVC BioPharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ABVC BioPharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ABVC BioPharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ABVC BioPharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ABVC BioPharma

Location

44370 OLD WARM SPRINGS BLVD

Fremont, California, United States

About

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology. The company has an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development, utilizing in-licensed technology from its network of world-renowned research institutions to conduct proof-of-concept trials through Phase II of clinical development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ABVC BioPharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ABVC BioPharma's next move

See what Strategic adds

ABVC BioPharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.